You are here: Industry Insights > Market News > Experts considering scientific evidence on need for booster dose against COVID

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Experts considering scientific evidence on need for booster dose against COVID

expresspharmaDecember 01, 2021

Tag: COVID-19 , Vaccine , NTAGI

Favorites

The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence for the need and justification for booster dose, Rajya Sabha was told yesterday.

Responding to a query on the stand of the Indian Government on booster doses, Bharati Pravin Pawar, Union Minister of State for Health, in a written reply said some countries are providing booster doses of COVID-19 vaccine.

“The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidences related to dose schedule of COVID vaccines as well as the need and justification for booster dose,” she said.

Previous:HPV Vaccine Is Reducing Cervical Cancers in Teens, Young Women

Next:Vaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: Fauci

Experts considering scientific evidence on need for booster dose against COVID

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may like
More>>

Experts considering scientific evidence on need for booster dose against COVID

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may likeMore>>

You may like
More>>